- Case Report
- Open Access
Central retinal vein occlusion concomitant with dengue fever
© Velaitham and Vijayasingham. 2016
Received: 14 September 2015
Accepted: 19 November 2015
Published: 20 January 2016
Dengue virus infection is on the rise and there is increasing number of ocular complications that are being reported. Most common ocular complications are macular edema, macular hemorrhages, and foveolitis. There are case reports on branch retinal vessel occlusions. Most of the ocular complications are attributed to the bleeding tendency and transudative process in dengue viral infection. This is a case report of ischemic central retinal vein occlusion (CRVO) concomitant with dengue fever.
A 41 year old Malay female was admitted to medical ward and diagnosed to have “dengue fever with warning signs”. On the day of admission she noted sudden onset of right eye blurring of vision. She presented to our clinic 1 week later. Ocular examination revealed right eye visual acuity of <20/1000 and ischaemic CRVO with macular edema. She had no other risk factors to develop retinal vein occlusion. She progressively developed proliferative retinopathy and received multiple laser therapy. There was no anterior segment neovascularization. However, her vision improved to only 20/400 despite of resolution of macular edema and new vessels elsewhere.
Dengue virus infection is known to cause thrombocytopenia which can result in hemorrhagic events. It can also cause procoagulant state which can result in thrombotic events secondary to immune reaction. Awareness among treating physicians of such ocular complication which can result in significant morbidity for patient is necessary.
Dengue is one of the most important arthropod-borne viral diseases in terms of human morbidity and mortality . The number of reported dengue viral infections in Malaysia is alarming and on the rise . Pathogenesis of severe dengue illness is attributed to increased vascular permeability and excessive bleeding caused by thrombocytopenia. There is an increasing evidence suggesting that abnormalities in the coagulation and fibrinolytic systems are also involved in dengue pathogenesis. Ocular complications following dengue fever include retinal hemorrhage, macular edema, retinal vasculitis and uveitis . We report a case of central retinal vein occlusion (CRVO) in dengue fever.
A 41 year old Malay female with no prior medical illness, was admitted to medical ward with the complain of fever, headache and reducing platelet and increasing hematocrit for 3 days duration. Her Dengue NS-1 antigen was reactive which confirms dengue virus infection. She was diagnosed to have ‘dengue fever with warning signs’ based on WHO classification of levels of severity . On admission she complained of right eye blurring of vision for 1 day. Fundus examination was done by medical officer in Medical ward and was documented normal. Therefore she was not referred to Ophthalmology department during the hospital stay. She was treated with fluid resuscitation and was discharged after 5 days. However, right eye blurring of vision persisted and then she was referred to the ophthalmologist. She presented to our eye clinic with right eye blurring of vision for 8 days. It was sudden in onset and non-progressive.
Ophthalmic complications following dengue fever are not uncommon. The spectrum of ophthalmic manifestations would lead one to conclude that several pathophysiologic processes are involved , namely thrombocytopenia, increased vascular permeability and inflammation. These changes manifest as anterior uveitis, retinal hemorrhage [4, 5], periphlebitis and macular edema [6, 7].
In this case, the thrombotic event may be related to immune response and down regulation of antithrombin. There are two different mechanisms described for this. Cabello et al. described that there is downregulation of cytoprotective protein C pathway in human endothelial vascular cells in Dengue infection. Profound endothelial damage caused by anti–NS1 antibody cross reaction with vascular endothelium result in reduction of thrombomodulin on endothelial surface . This in turn reduces activated protein C (APC) generation. Downregulation of APC anticoagulant pathway promotes thrombosis . Conversely, Mairuhu et al. measured plasma level of plasminogen activator inhibitor type 1 (PAI-1) concentrations in patients who were admitted with clinically suspected severe dengue virus infection. They demonstrated an increase in PAI-1 plasma level in individuals with dengue virus infection and in particular in those with poor clinical outcome. Primary role of PAI-1 is to inhibit fibrinolytic activity in vivo . These factors attribute to the procoagulant state and are associated with greater risk for thrombosis .
Similarly, several major vessel thrombotic events were reported during dengue infection in Brazil. These patients account for 5.4 % of all dengue inpatients. Severe dehydration, a well known condition associated with thrombotic events, was not detected in any of these patients. Likewise, thrombotic events in these patients were thought to be due to loss of endothelial non-thrombogenic protective factors early in the course of the disease .
In this case the onset of symptoms did not coincide with highest hemoconcentration state or lowest platelet level. It occurred early in the disease process which would suggest that immune reaction could be the cause of thrombosis. The most common ocular manifestation of dengue virus infection is macular edema, macular hemorrhage and foveolitis . Retinal hemorrhages are common and can be associated with cotton wool spots. In this patient, cotton wool spots were numerous and around peridisc region. This is in keeping with CRVO and reflects the severity of retinal ischemia. As a consequences this patient developed proliferative retinopathy which is seen in 9 % of CRVO patients within 6 months from onset . Early commencement of laser therapy could have reduced vascular endothelial growth factor level in the vitreous and prevented anterior segment neovascularization.
This patient was treated with panretinal photocoagulation for proliferative retinopathy. Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection is the preferred modality of treatment in some countries . However, in our setting it is yet to be approved for the use in macular edema secondary to CRVO. The macular edema improved drastically within 2 months which was confirmed with OCT imaging and her vision improved from <20/1000 to 20/400.
To our best knowledge, this is the first case report of ischemic CRVO in Dengue fever. This adds to the evidence that Dengue fever has an immunologic component in its pathogenesis. Future study is warranted to ascertain if immunosuppressive therapy is beneficial in such patients. Attending doctors should be aware of diverse ophthalmic complications of dengue fever and co-manage with ophthalmologist to prevent and reduce morbidity.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images.
VP: has been involved in acquisition of data and drafting manuscript. VN: has been revising manuscript critically for important intellectual content and has given final approval of the version to be published. Both authors read and approved the final manuscript.
The authors declare that there is no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Dengue guidelines for diagnosis, treatment, prevention and control. World Health Organization. 2009 edition. Available from: http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf.
- Clinical practice guidelines MOH/P/PAK/209.10 (GU) management of dengue infection in adults (Revised 2nd edition). 2010.Google Scholar
- Chan DPL, Teoh SCB, Tan CSH, Nah GKM, Rajagopalan R, Prabhakaragupta MK, Chee CKL, Lim TH, Goh KY. Ophthalmic complications of dengue. Emerg Infect Dis. 2006;12(2):285–9.PubMedPubMed CentralView ArticleGoogle Scholar
- Kanungo S, Shukla D, Kim R. Branch retinal artery occlusion secondary to dengue fever. Indian J Ophthalmol. 2008;56:73–4.PubMedPubMed CentralView ArticleGoogle Scholar
- Preechawat Pisit, Poonyathalang Anuchit, Kurathong Sireedhorn, Leelawongs Kitikul, Pangthanapisit Viroj. Non-ischaemic central retinal vein occlusion after dengue viral infection. Neuro-ophthalmol. 2012;36(1):26–8.View ArticleGoogle Scholar
- Quek DTL, Barkham T, Teoh SCB. Recurrent bilateral dengue maculopathy following sequential infections with two serotypes of dengue virus. Eye. 2009;23:1471–2.PubMedView ArticleGoogle Scholar
- Tan CSH, Teoh SCB, Chan DPL, Wong IBY, Lim TH. Dengue retinopathy manifesting with bilateral vasculitis and macular oedema. Eye. 2007;21:875–7.PubMedView ArticleGoogle Scholar
- Cabello-Gutiérrez C, Manjarrez-Zavala ME, Huerta-Zepeda A, Cime-Castillo J, Monroy-Martínez V, Correa BB, Thromb Haemost. Modification of the cytoprotective protein C pathway during dengue virus infection of human endothelial vascular cells. Thromb Hemost. 2009;101(5):916–28.Google Scholar
- Mairuhu AT, Setiati TE, Koraka P, Hack CE, Leyte A, Faradz SM, ten Cate H, Brandjes DP, Osterhaus AD, Reitsma PH, van Gorp EC. Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism. Thromb J. 2005. doi:10.1186/1477-9560-3-17.PubMedPubMed CentralGoogle Scholar
- da Costa PS, Ribeiro GM, Junior CS, da Costa Campos L. Short report: severe thrombotic events associated with dengue fever, Brazil. Am J Trop Med Hyg. 2012;87(4):741–2.PubMedPubMed CentralView ArticleGoogle Scholar
- Yip VC, Sanjay S, Koh YT. Ophthalmic complications of dengue fever: a systemic review. Ophthalmol Ther. 2012;1:2. doi:10.1007/s40123-012-0002-z.PubMedPubMed CentralView ArticleGoogle Scholar
- Hayreh SS, Zimmerman MB. Ocular Neovascularization associated with central and hemicentral retinal vein occlusion. Retina. 2012;32(8):1553–65.PubMedView ArticleGoogle Scholar
- Karia Niral. Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol. 2010;4:809–16.PubMedPubMed CentralView ArticleGoogle Scholar